Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7195 p568-572
27 April 2002

This page
Reprint
Photocopy

   

PDF* 80K

Letters

  Prescribing
  CPP
  Checking technicians
  CPD
  Compliance aids
  Childhood vaccination
  Packaging
  Community pharmacy
  LPS
  HRT
  Hospital Pharmacy
  The Society
  Honorary auditors
  PJ Online


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

HRT

Link between vascular calcification and bone resorption

From Professor R. Corder, MRPharmS

I noted with interest your recent news item highlighting that hormone replacement therapy reduces arterial calcification (PJ, 13 April, p488). Although I have not read the paper you cited, I would like to bring to the attention of your readership the close link between vascular calcification and bone resorption.1 Indeed, the observations by Dr Julie Cox and colleagues of increased mammary vessel calcification in patients not receiving HRT may also be interpreted as indicating those patients who are suffering the greatest degree of osteoporosis.

Reference

1. Hofbauer LC, Schoppet M. Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 2001;358:257–9.

Roger Corder
Professor of Experimental Therapeutics,
William Harvey Research Institute,
Barts and the London,
Queen Mary's School of Medicine and Dentistry, London EC1

 

Previous Topic (LPS)
Next Topic (Hospital pharmacy)
Send your letter to The Editor

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal